NARA Discovery
Article Details
← Back to Search Results
Journal Article

Pseudoteratosphaeria supramediana sp. nov. (Teratosphaeriaceae, Mycosphaerellales), a New Foliar Pathogen on Eucalyptus in Indonesia

Nam Q. Pham; Seonju Marincowitz; Brenda D. Wingfield; Pedro W. Crous; Samuel A. Santos; Alvaro Durán; Marthin Tarigan; Michael J. Wingfield
Australasian Plant Pathology · Vol. 55, Issue 2 · 2026

Abstract

The Eucalyptus plantation industry in Indonesia has expanded rapidly during the last few decades. This growth is primarily attributed to the replacement of Acacia mangium , that was severely damaged by diseases. The rapid shift to large-scale monoculture plantations of Eucalyptus has introduced new challenges, particularly the emergence of new disease and pest problems. During routine Eucalyptus disease surveys in Indonesia, symptoms of a new leaf and shoot disease were observed on a single hybrid Eucalyptus grandis × pellita clone in Riau and Kalimantan. Leaf samples were collected, and isolations were made from the disease symptoms. Isolates were identified based on their morphological characteristics and DNA sequence data for seven loci. Phylogenetic analyses of the isolates revealed a novel species of Pseudoteratosphaeria , described here as Pseudoteratosphaeria supramediana sp. nov. A greenhouse pathogenicity test resulted in symptoms similar to those found under field conditions, and the inoculated fungus was consistently reisolated from the resulting lesions. Its appearance in two geographically distinct locations of Indonesia raises the possibility of multiple independent introductions of the pathogen.

Bibliographic Information

JournalAustralasian Plant Pathology
PublisherSpringer
Publication Date2026-04-01
Publication Year2026
Volume55
Issue2
Document TypeJournal Article
Print ISSN0815-3191
eISSN1448-6032
DOI10.1007/s13313-026-01092-3

Access Information

NARA Access Coverage1972-01-01~Current
Journal Homepagehttps://www.springer.com/journal/13313
Publisher PageOpen Publisher Page
Full-text access depends on NARA's subscribed coverage and institutional access.